Compare Nuwellis Inc (NUWE) vs Rush Street Interactive Inc (RSI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs Rush Street Interactive Inc — how do they compare? Nuwellis Inc trades at $0.7 (market cap $2.20M), while Rush Street Interactive Inc trades at $20.26 (market cap $2.35B). The key difference: Rush Street Interactive Inc is far larger — about 1068.2× Nuwellis Inc's market cap, and Rush Street Interactive Inc is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nuwellis Inc for 26 Days and Rush Street Interactive Inc for 13 Days on average.
| NUWE | RSI | |
|---|---|---|
Market Cap | $2.20M | $2.35B |
Volume | 121,544 | 2,219,374 |
Sector | Health | Consumer Cyclical |
52-Week High | $146.65 | $34.52 |
52-Week Low | $0.68 | $15.89 |
Typical Hold Time | 26 Days | 13 Days |
Enterprise Value | -$1.52M | $2.01B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.
The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.
RSI trades at $20.24, down 1.56% with bearish technical signals but strong analyst support. The company shows revenue growth from $1.13B in 2025 to $1.4B projected for 2026, though net income margin compressed from 2.93% to 2.33%. Recent Q2 2026 earnings beat expectations with $0.15 EPS versus $0.1499 expected. Technical indicators show mixed signals with moving averages bearish but oscillators neutral, while institutional activity includes BlackRock's $448M investment in August 2026.
The stock presents a compelling valuation gap with consensus price target of $34.88 representing 72% upside, supported by 77% buy ratings from analysts. Key risks include competitive pressures in online gaming and margin compression despite revenue growth. The company's participation in major industry conferences and strong institutional backing provides fundamental support for long-term growth prospects.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About Rush Street Interactive Inc
Rush Street Interactive, Inc. is a digital gaming and sports betting company operating in the regulated U.S. and international markets. The company owns and operates online casino (iGaming) and sports wagering platforms, including BetRivers and PlaySugarHouse brands. RSI focuses on providing a secure and high-quality online gaming experience, leveraging its proprietary technology platform and commitment to responsible gaming.
Read more on RSI →
